| Expression of 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue is not increased in human obesity. PMS J.W.Tomlinson, B.Sinha, I.Bujalska, M.Hewison J Clin Endocrinol Metab. 87 (12), 5630-5., 2002 | 247 | 2002 |
| Estimation of effects of nationwide lockdown for containing coronavirus infection on worsening of glycosylated haemoglobin and increase in diabetes-related complications: a … S Ghosal, B Sinha, M Majumder, A Misra Diabetes & Metabolic Syndrome: Clinical Research & Reviews 14 (4), 319-323, 2020 | 238 | 2020 |
| Androgen generation in adipose tissue in women with simple obesity–a site-specific role for 17β-hydroxysteroid dehydrogenase type 5 M Quinkler, B Sinha, JW Tomlinson, IJ Bujalska, PM Stewart, W Arlt Journal of Endocrinology 183 (2), 331-342, 2004 | 227 | 2004 |
| Linear Regression Analysis to predict the number of deaths in India due to SARS-CoV-2 at 6 weeks from day 0 (100 cases-March 14th 2020) S Ghosal, S Sengupta, M Majumder, B Sinha Diabetes & Metabolic Syndrome: Clinical Research & Reviews 14 (4), 311-315, 2020 | 156 | 2020 |
| Meta-analyses of the effects of DPP-4 inhibitors, SGLT2 inhibitors and GLP1 receptor analogues on cardiovascular death, myocardial infarction, stroke and hospitalization for … B Sinha, S Ghosal Diabetes research and clinical practice 150, 8-16, 2019 | 122 | 2019 |
| Maternal ante‐natal parameters as predictors of persistent postnatal glucose intolerance: a comparative study between Afro‐Caribbeans, Asians and Caucasians B Sinha, P Brydon, RS Taylor, A Hollins, A Munro, D Jenkins, F Dunne Diabetic Medicine 20 (5), 382-386, 2003 | 100 | 2003 |
| Increase in the risk of type 2 diabetes during lockdown for the COVID19 pandemic in India: a cohort analysis S Ghosal, B Arora, K Dutta, A Ghosh, B Sinha, A Misra Diabetes & Metabolic Syndrome: Clinical Research & Reviews 14 (5), 949-952, 2020 | 95 | 2020 |
| Management and 1‐year outcomes of patients with newly diagnosed atrial fibrillation and chronic kidney disease: results from the prospective GARFIELD‐AF registry S Goto, P Angchaisuksiri, JP Bassand, AJ Camm, H Dominguez, ... Journal of the American Heart Association 8 (3), e010510, 2019 | 60 | 2019 |
| A meta-analysis of the effects of glucagon-like-peptide 1 receptor agonist (GLP1-RA) in nonalcoholic fatty liver disease (NAFLD) with type 2 diabetes (T2D) S Ghosal, D Datta, B Sinha Scientific Reports 11 (1), 22063, 2021 | 58 | 2021 |
| Assessing the need for pioglitazone in the treatment of patients with type 2 diabetes: a meta-analysis of its risks and benefits from prospective trials B Sinha, S Ghosal Scientific Reports 10 (1), 15781, 2020 | 34 | 2020 |
| The effect of angiotensin converting enzyme inhibitors and angiotensin receptor blockers on death and severity of disease in patients with coronavirus disease 2019 (COVID-19 … S Ghosal, JJ Mukherjee, B Sinha, K Gangopadhyay medRxiv, 2020.04. 23.20076661, 2020 | 33 | 2020 |
| Consensus statement on insulin therapy in chronic kidney disease R Rajput, B Sinha, S Majumdar, M Shunmugavelu, S Bajaj Diabetes Research and Clinical Practice 127, 10-20, 2017 | 32 | 2017 |
| Pioglitazone—do we really need it to manage type 2 diabetes? B Sinha, S Ghosal Diabetes & Metabolic Syndrome: Clinical Research & Reviews 7 (1), 52-55, 2013 | 28 | 2013 |
| Evidence-based consensus on positioning of SGLT2i in type 2 diabetes mellitus in Indians AK Singh, AG Unnikrishnan, AH Zargar, A Kumar, AK Das, B Saboo, ... Diabetes Therapy 10, 393-428, 2019 | 27 | 2019 |
| Importance of achieving the composite endpoints in diabetes AG Unnikrishnan, A Bhattacharyya, MP Baruah, B Sinha, ... Indian journal of endocrinology and metabolism 17 (5), 835-843, 2013 | 24 | 2013 |
| Liraglutide and Dulaglutide therapy in addition to SGLT-2 inhibitor and metformin treatment in Indian type 2 diabetics: a real world retrospective observational study S Ghosal, B Sinha Clinical Diabetes and Endocrinology 4, 1-7, 2018 | 21 | 2018 |
| The role of corticosteroids in the management of critically ill patients with coronavirus disease 2019 (COVID-19): A meta-analysis KK Gangopadhyay, JJ Mukherjee, B Sinha, S Ghosal MedRxiv, 2020.04. 17.20069773, 2020 | 20 | 2020 |
| Sodium-glucose cotransporter-2 inhibitors (SGLT-2i) reduce hospitalization for heart failure only and have no effect on atherosclerotic cardiovascular events: a meta-analysis B Sinha, S Ghosal Diabetes Therapy 10, 891-899, 2019 | 18 | 2019 |
| Meta‐analysis of the effects of sodium glucose cotransporter 2 inhibitors in non‐alcoholic fatty liver disease patients with type 2 diabetes B Sinha, D Datta, S Ghosal JGH Open 5 (2), 219-227, 2021 | 16 | 2021 |
| Assessing prevalence and predictors of depression in Type 2 Diabetes Mellitus (DM) patients–The DEPDIAB study S Majumdar, B Sinha, BG Dastidar, KK Gangopadhyay, S Ghoshal, ... Diabetes research and clinical practice 178, 108980, 2021 | 15 | 2021 |
